An ISO 9001:2008
COMPANY

Write to us on the following email id to get specific quote sales@veeprholabs.com

Aceclofenac Impurity F / Aceclofenac Benzyl Ester

CAS No. 100499-89-6

Catalogue No : VL284001
Category : Aceclofenac Impurity
CAS No. : 100499-89-6

IUPAC Name : 2-[(2,6-Dichlorophenyl) amino] benzeneacetic Acid 2-Oxo-2-(phenyl methoxy)ethyl Ester

Molecular Weight : 444.00 g/mol

Molecular Formula : C23H19Cl2NO4

 

Get a Quote
Write to us on the following email id to get specific quote sales@veeprholabs.com


PRODUCT DESCRIPTION

Welcome to Veeprho Laboratories, manufacturer and supplier of Aceclofenac Impurity F (CAS No. 100499-89-6). We are manufacturer and supplier of all Aceclofenac Impurities which are acceptable to all regulatory agencies in the world like US-FDA, MHRA, MCC, WHO, Brazil, Japan. These Aceclofenac impurities are provided with certificate of analysis (COA) along with the characterization data like NMR MASS IR and HPLC Purity.


Veeprho Laboratories is a manufacturer and supplier of Aceclofenac APIs, Aceclofenac Intermediates and isolation of unknown impurity with structure elucidation with help of C NMR, H NMR, MASS, CHN, HPLC data. We are also supplier of all Aceclofenac USP, EP, BP pharmacopoeia impurity. On request we also manufacture and supply all impurities of Aceclofenac as per pharmacopoeia RRT.


We are manufacturer and supplier of all Aceclofenac impurities like Aceclofenac impurity F / Aceclofenac Benzyl Ester (CAS No. 100499-89-6), Aceclofenac Impurity D / Aceclofenac Methyl Ester (CAS No. 139272-66-5), Aceclofenac Impurity E / Aceclofenac Ethyl Ester (CAS No. 139272-67-6), Aceclofenac Impurity I / Diclofenac Impurity A (CAS No. 15362-40-0), Aceclofenac Impurity B / Diclofenac Methyl Ester (CAS No. 15307-78-5), Aceclofenac Impurity C / Diclofenac Ethyl Ester, Aceclofenac Impurity A / Diclofenac Sodium, Aceclofenac EP Impurity G which are to be isolated by preparative HPLC and Lyophillized. These Aceclofenac impurities are also used for ANDA filling/DMF filling and genotoxic study.